AAP
TNDM icon

Arax Advisory Partners’s Tandem Diabetes Care TNDM Stock Holding History

Arax Advisory Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3K Buy
748
+250
+50% +$5.43K ﹤0.01% 2261
2025
Q4 		$10.9K Sell
498
-6,653
-93% -$120K ﹤0.01% 2419
2025
Q3 		$86.8K Buy
7,151
+6,675
+1,402% +$90.4K ﹤0.01% 1583
2025
Q2 		$8.87K Buy
476
+59
+14% +$1.17K ﹤0.01% 2014
2025
Q1 		$7.99K Buy
417
+400
+2,353% +$11.7K ﹤0.01% 1628
2024
Q4 		$613 Sell
17
-9
-35% -$304 ﹤0.01% 2287
2024
Q3 		$1.1K Buy
26
+10
+63% +$424 ﹤0.01% 2217
2024
Q2 		$645 Buy
+16
New +$668 ﹤0.01% 2286

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arax Advisory Partners's TNDM Position: Q1 2026 in Review

Arax Advisory Partners increased its Tandem Diabetes Care (TNDM) stake by 50% in Q1 2026, buying an estimated $5.43K and bringing the position to 748 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

Arax Advisory Partners first reported a position in TNDM in Q2 2024 and has held it in 8 quarters since. The position peaked at $86.8K in Q3 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Arax Advisory Partners held 748 shares of Tandem Diabetes Care worth $14.3K as of Q1 2026.
  • Arax Advisory Partners bought 250 Tandem Diabetes Care shares in Q1 2026, an estimated $5.43K.
  • Tandem Diabetes Care made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2261 holding.
  • Arax Advisory Partners first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's Tandem Diabetes Care position peaked at $86.8K in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.